Sacituzumab, CAS [[1796566-95-4]]

Produktübersicht

• Artikelname: Sacituzumab, CAS [[1796566-95-4]]
• Artikelnummer: MCE-HY-P99045
• Hersteller Artikelnummer: HY-P99045
• Alternativnummer: MCE-HY-P99045-1MG,MCE-HY-P99045-100MG,MCE-HY-P99045-50MG,MCE-HY-P99045-10MG,MCE-HY-P99045-5MG,MCE-HY-P99045-25MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: HRS7, hRS7

Produktbeschreibung

Sacituzumab is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab can be used for the synthesis of antibody-drug conjugates (ADC) drug Sacituzumab govitecan (HY-132254). Sacituzumab govitecan can be used in the field of triple-negative breast cancer[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: (145.52 kDa)
• Reinheit: 99.9
• CAS Nummer: [1796566-95-4]
• Target-Kategorie: ADC Antibody,TROP2

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies